What causes influenza to progress to pneumonia? That’s a question many healthy adults don’t ask because you can usually count on your immune system to defeat the flu virus. Yes, you’ll have to endure ...

When complications of pneumonia do develop in the pregnant patient ... Aminoglycosides should only be used if there is evidence of serious gram-negative infection, because the risk of ototoxicity ...

Aug. 6, 2024 — An AI-based analysis of over 2 million hospital visits has found that most of the time, a pneumonia diagnosis made in the hospital will change from a patient's entrance to their ...

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Pneumonia symptoms can vary based on the cause and severity of the lung infection. For some, it might feel similar to the flu or be barely noticeable. For others, pneumonia can cause severe ...

12 Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Introduction Ventilator-associated ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

Background: Nosocomial pneumonia is a major health and economic burden globally. Multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria are the most common causative ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...